A study of the local tolerance of tibicorten during long-term application.
Regular observation of 16 patients with chronic skin diseases, treated twice daily with applications of Tibicorten for 2 to 14 weeks, showed that this treatment did not give rise to development of local side-effects. Even protracted local application of Tibicorten is tolerated excellently.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000031:analogs & derivatives / Q000627:therapeutic use*
D014222:Triamcinolone Acetonide